Belite Bio, Inc. (BLTE)
177.46
-5.70
(-3.11%)
USD |
NASDAQ |
Sep 10, 12:51
Belite Bio Total Assets (Quarterly) : 791.58M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 791.58M |
| March 31, 2026 | 811.27M |
| December 31, 2025 | 780.56M |
| September 30, 2025 | 282.39M |
| June 30, 2025 | 156.41M |
| March 31, 2025 | 164.20M |
| December 31, 2024 | 152.13M |
| Date | Value |
|---|---|
| September 30, 2024 | 115.82M |
| June 30, 2024 | 118.43M |
| March 31, 2024 | 101.15M |
| December 31, 2023 | 94.64M |
| September 30, 2023 | 57.60M |
| June 30, 2023 | 60.70M |
| March 31, 2023 | 39.82M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | 103.90M |
| CorMedix, Inc. | 904.05M |
| Eloxx Pharmaceuticals, Inc. | 63.39M |
| Cannabis Global, Inc. | 0.885M |
| Breakthrough Chemistry, Inc. | 1.300M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 14.95M |
| Shareholders Equity (Quarterly) | 776.64M |